TGFB1 and musculoskeletal system disorder: However, studies examining tendosynovial tissues collected from patients with upper extremity musculoskeletal disorders during surgical intervention show increased tissue fibrogenic and degradative proteins (e.g., transforming growth factor beta 1 and matrix metalloproteases) and fibrotic histopathology [7], [11], [23], [24], [25].